drugset / Trial / NCT06880874

A Clinical Study to Evaluate Enlicitide (MK-0616) Formulations in Healthy Adult Participants (MK-0616-035)

NCT06880874

Phase 1 Completed 40 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverOpen-labelBasic science

Summary

The goal of the study is to learn what happens to different forms of enlicitide medications in a healthy person's body over time. Researchers will compare the amount of enlicitide in the healthy person's body over time when enlicitide is given in different formulations.

Timeline

Start
2025-04-02
Primary completion
2025-05-16
Completion
2025-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Enlicitide Unknown Oral

Indications

No indication recorded.